🇺🇸 FDA
Patent

US 7825154

Small molecule inhibitors of botulinum neurotoxins

granted A61KA61K31/4184A61K31/423

Quick answer

US patent 7825154 (Small molecule inhibitors of botulinum neurotoxins) held by The United States of America as represented by the Secretary of the Army expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/4184, A61K31/423, A61K31/427, A61K31/428